Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.

Antimicrobial Agents and Chemotherapy
N MbongoM Robert-Gero

Abstract

Amphotericin B (AmB)-resistant Leishmania donovani promastigotes were selected by increasing drug pressure, and their biological features were compared with those of the wild-type parent strain. The 50% inhibitory concentration for resistant cells was 20 times higher than that for the wild-type. Resistance was stable after more than 40 passages in drug-free medium, and resistant promastigotes were infective to macrophages in vitro but lost their virulence in vivo. They had 2.5 times longer generation time, decreased AmB uptake, and increased AmB efflux in comparison to the wild type. Fluorescence measurement with a specific plasma membrane probe, 1-[4-(trimethylammonio)-1,6-diphenylhexa]-1,3,5-triene, showed increased membrane fluidity in drug-resistant promastigotes. Analysis of lipid composition showed that in resistant cells saturated fatty acids were prevalent, with stearic acid as the major fatty acid, and the major sterol was an ergosterol precursor, the cholesta-5, 7, 24-trien-3beta-ol and not ergosterol as in the AmB-sensitive strain.

References

Oct 26, 1976·Biochimica Et Biophysica Acta·R A Demel, B De Kruyff
Jun 2, 1979·Biochimica Et Biophysica Acta·N D LeesF W Kleinhans
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·J D BermanW L Hanson
Oct 1, 1991·The American Journal of Tropical Medicine and Hygiene·C P ThakurA K Pandey
May 4, 1991·Lancet·R N DavidsonA D Bryceson
Sep 1, 1988·Annales De L'Institut Pasteur. Microbiology·M Mpona-MingaR Bonaly
Aug 7, 1987·Journal of Chromatography·C BrassinneF Meunier
Mar 1, 1985·The Journal of Cell Biology·P GreenspanS D Fowler
Jun 1, 1985·Molecular and Biochemical Parasitology·L J GoadD H Beach
Apr 16, 1973·Biochemical and Biophysical Research Communications·C C HsuChen, D S Feingold
Jan 1, 1983·CRC Critical Reviews in Biochemistry·K E Bloch
Feb 1, 1984·Molecular and Biochemical Parasitology·L J GoadD H Beach
Oct 1, 1994·Trends in Microbiology·H Vanden BosscheF C Odds
Jan 1, 1993·Parasitology Research·M A PhelouzatM Robert-Gero
Jan 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R D Pearson, A Q Sousa
Oct 1, 1996·Clinical Microbiology Reviews·J Brajtburg, J Bolard
Dec 1, 1996·Trends in Pharmacological Sciences·S Hartsel, J Bolard
Jan 1, 1997·Parasitology Research·M MaaroufM Robert-Gero
Jun 1, 1965·Journal of Bacteriology·E K HEBEKA, M SOLOTOROVSKY

❮ Previous
Next ❯

Citations

Feb 16, 2002·Experimental Parasitology·A K SinghM Ouellette
Oct 23, 2009·The Journal of Physical Chemistry. B·Katarzyna Hac-WydroRadosław Zuk
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·P M LoiseauI De Miguel
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Vijay Kumar PrajapatiShyam Sundar
Jun 28, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Radhika MathurChandrima Shaha
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·S L Croft
Jun 22, 2002·International Journal for Parasitology·E CauchetierM Paul
May 11, 2016·Proceedings of the National Academy of Sciences of the United States of America·Élodie GazanionMarc Ouellette
Aug 2, 2008·Journal of Enzyme Inhibition and Medicinal Chemistry·Patrice Le Pape
Aug 11, 2011·The Pediatric Infectious Disease Journal·Juan A HervásJoaquín Dueñas
Jan 1, 2015·International Scholarly Research Notices·Rogério AndréoRegina Maria Barretto Cicarelli
Sep 16, 2016·Jundishapur Journal of Microbiology·Imran KhanDeog-Hwan Oh
Nov 30, 2011·Antimicrobial Agents and Chemotherapy·Bidyut PurkaitPradeep Das
Dec 30, 2011·PLoS Neglected Tropical Diseases·Ana Marta SilvaGraham H Coombs
Jan 21, 2017·Parasitology·Silvia R B UlianaAdriano C Coelho
Apr 24, 2021·Nanomedicine·Mahboobeh JafariBahador Shahriarirad Sarkari
Apr 4, 2012·Emerging Infectious Diseases·Sandrine CojeanSophie Matheron
May 12, 2012·Asian Pacific Journal of Tropical Medicine·Nisha SinghRakesh Kumar Singh
Nov 30, 2018·Drug Delivery and Translational Research·Aiman Abu AmmarZiad Abdeen
Jun 18, 2017·PLoS Neglected Tropical Diseases·Roy MwenechanyaMichael P Barrett
Jun 22, 2017·Nanomedicine·Hafiz Shoaib SarwarGul Shahnaz
Dec 12, 2018·Journal of Biomolecular Structure & Dynamics·Haraprasad MandalPradeep Das
Aug 29, 2012·The American Journal of Tropical Medicine and Hygiene·Vijay Kumar PrajapatiShyam Sundar
Sep 8, 2012·Future Microbiology·Alexandra K MarrW Robert McMaster
Sep 7, 2017·Journal of Liposome Research·Vanessa OrtegaEneida de Paula
May 18, 2021·Frontiers in Cellular and Infection Microbiology·Elvira Cynthia Alves HorácioLaila Alves Nahum
May 21, 2021·International Journal for Parasitology. Drugs and Drug Resistance·Myriam GonzálezRafael Peláez
Jan 4, 2013·PLoS Neglected Tropical Diseases·Raquel García-HernándezFrancisco Gamarro
Jun 28, 2019·Fungal Genetics and Biology : FG & B·Roya Vahedi Shahandashti, Cornelia Lass-Flörl
Apr 12, 2005·Applied Microbiology and Biotechnology·A LemkeO Kayser
May 1, 2013·Infection and Immunity·Chaoqun YaoMary E Wilson
Dec 15, 2017·PLoS Neglected Tropical Diseases·Alicia Ponte-SucreBarbara Papadopoulou
Sep 13, 2019·European Journal of Medicinal Chemistry·Susana Santos Braga
Jul 2, 2003·The Journal of Pharmacy and Pharmacology·Sophia G AntimisiarisPhilippe M Loiseau
Sep 15, 2009·The Journal of Antimicrobial Chemotherapy·M Saint-Pierre-ChazaletP M Loiseau
Oct 8, 2013·Parasitology Research·Alana Freire de AzevedoRoberta Pereira Miranda Fernandes
Oct 23, 2013·Future Medicinal Chemistry·Masoom YasinzaiGul Shahnaz
Jan 1, 2014·Molecular and Cellular Biochemistry·Juliana Tonini MesquitaAndré Gustavo Tempone
Nov 26, 2003·Antimicrobial Agents and Chemotherapy·Malika LarabiGillian Barratt

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.